Apellis Pharmaceuticals, Inc. - APLS

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 30
Latest filed: Jun 05, 2026
Form Count
4 21
SCHEDULE 13G/A 5
8-K 3
SCHEDULE 13D/A 1

Latest files

Filed Form Report period Accession SEC
Jun 05, 2026 SCHEDULE 13G/A 0000895421-26-000190 View
May 15, 2026 SCHEDULE 13G/A 0001172661-26-002024 View
May 15, 2026 SCHEDULE 13G/A 0001493215-26-000090 View
May 14, 2026 4 May 14, 2026 0001193125-26-224577 View
May 14, 2026 4 May 14, 2026 0001193125-26-224579 View
May 14, 2026 4 May 14, 2026 0001193125-26-224583 View
May 14, 2026 4 May 14, 2026 0001193125-26-224585 View
May 14, 2026 4 May 14, 2026 0001193125-26-224589 View
May 14, 2026 4 May 14, 2026 0001193125-26-224592 View
May 14, 2026 4 May 14, 2026 0001193125-26-224597 View
May 14, 2026 4 May 14, 2026 0001193125-26-224601 View
May 14, 2026 4 May 14, 2026 0001193125-26-224604 View
May 14, 2026 4 May 14, 2026 0001193125-26-224606 View
May 14, 2026 4 May 14, 2026 0001193125-26-224609 View
May 14, 2026 4 May 14, 2026 0001193125-26-224611 View
May 14, 2026 4 May 14, 2026 0001193125-26-224615 View
May 14, 2026 4 May 14, 2026 0001193125-26-224618 View
May 14, 2026 4 May 14, 2026 0001193125-26-224620 View
May 14, 2026 4 May 14, 2026 0001193125-26-224624 View
May 14, 2026 4 May 14, 2026 0001193125-26-224627 View
May 14, 2026 4 May 14, 2026 0001193125-26-224633 View
May 14, 2026 SCHEDULE 13D/A 0000950157-26-000611 View
May 14, 2026 8-K May 14, 2026 0001193125-26-222923 View
May 04, 2026 8-K Apr 28, 2026 0001193125-26-202504 View
May 01, 2026 4 Apr 29, 2026 0001492422-26-000105 View
Apr 20, 2026 4 Apr 17, 2026 0001193125-26-163917 View
Apr 08, 2026 4 Apr 06, 2026 0001492422-26-000099 View
Apr 07, 2026 SCHEDULE 13G/A 0000902219-26-000117 View
Mar 31, 2026 8-K Mar 30, 2026 0001193125-26-134916 View
Mar 26, 2026 SCHEDULE 13G/A 0000102909-26-000675 View